New hope for hemophilia a: experimental drug NXT007 enters human trials
NCT ID NCT05987449
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This study tests a new medicine called NXT007 for people with severe or moderate hemophilia A, a bleeding disorder. The trial includes adults, teenagers, and children, both with and without inhibitors that make standard treatment less effective. Researchers will check if the drug is safe, how the body processes it, and whether it helps control bleeding episodes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Auckland Cancer Trial Centre
RECRUITINGAuckland, 1023, New Zealand
-
British Columbia Children's Hospital
RECRUITINGVancouver, British Columbia, V6H 3N1, Canada
-
Georgetown Uni Medical Center
WITHDRAWNWashington D.C., District of Columbia, 20007, United States
-
Hamilton Health Sciences Corporation
RECRUITINGHamilton, Ontario, L8N 3Z5, Canada
-
Hospital Regional Universitario Carlos Haya
ACTIVE_NOT_RECRUITINGMálaga, 29010, Spain
-
Hospital Sant Joan de Deu
RECRUITINGEsplugues de Llobregat, Barcelona, 08950, Spain
-
Hospital Universitario la Paz
ACTIVE_NOT_RECRUITINGMadrid, 28046, Spain
-
IRCCS Ca' Granda Ospedale Maggiore Policlinico
RECRUITINGMilan, Lombardy, 20122, Italy
-
Indiana Hemophilia & Thrombosis center
RECRUITINGIndianapolis, Indiana, 46260, United States
-
Instytut Hematologii i Transfuzjologii
RECRUITINGWarsaw, 02-776, Poland
-
Istituto Clinico Humanitas
RECRUITINGRozzano (MI), Lombardy, 20089, Italy
-
UC Davis Cancer Center
RECRUITINGSacramento, California, 95817, United States
-
University of Iowa Hospitals and Clnics Dept of Pediatrics
RECRUITINGIowa City, Iowa, 52242, United States
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGda?sk, 80-214, Poland
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.